nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—KCNMA1—saliva-secreting gland—thyroid cancer	0.00912	0.0927	CbGeAlD
Hydrochlorothiazide—CA4—neck—thyroid cancer	0.00694	0.0706	CbGeAlD
Hydrochlorothiazide—CA12—trachea—thyroid cancer	0.00675	0.0686	CbGeAlD
Hydrochlorothiazide—CA2—neck—thyroid cancer	0.00576	0.0585	CbGeAlD
Hydrochlorothiazide—KCNMA1—thyroid gland—thyroid cancer	0.00557	0.0566	CbGeAlD
Hydrochlorothiazide—CA4—saliva-secreting gland—thyroid cancer	0.00542	0.0551	CbGeAlD
Hydrochlorothiazide—KCNMA1—head—thyroid cancer	0.00494	0.0502	CbGeAlD
Hydrochlorothiazide—CA5B—thyroid gland—thyroid cancer	0.00479	0.0487	CbGeAlD
Hydrochlorothiazide—CA12—head—thyroid cancer	0.00474	0.0481	CbGeAlD
Hydrochlorothiazide—CA2—saliva-secreting gland—thyroid cancer	0.00449	0.0456	CbGeAlD
Hydrochlorothiazide—CA5B—head—thyroid cancer	0.00425	0.0432	CbGeAlD
Hydrochlorothiazide—CA4—trachea—thyroid cancer	0.00418	0.0425	CbGeAlD
Hydrochlorothiazide—CA1—head—thyroid cancer	0.00375	0.0381	CbGeAlD
Hydrochlorothiazide—CA2—trachea—thyroid cancer	0.00346	0.0352	CbGeAlD
Hydrochlorothiazide—KCNMA1—lymph node—thyroid cancer	0.00346	0.0351	CbGeAlD
Hydrochlorothiazide—CA4—thyroid gland—thyroid cancer	0.00331	0.0336	CbGeAlD
Hydrochlorothiazide—CA5B—lymph node—thyroid cancer	0.00297	0.0302	CbGeAlD
Hydrochlorothiazide—CA4—head—thyroid cancer	0.00293	0.0298	CbGeAlD
Hydrochlorothiazide—CA2—thyroid gland—thyroid cancer	0.00274	0.0279	CbGeAlD
Hydrochlorothiazide—CA1—lymph node—thyroid cancer	0.00263	0.0267	CbGeAlD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EPO—thyroid cancer	0.00262	0.135	CbGpPWpGaD
Hydrochlorothiazide—CA2—head—thyroid cancer	0.00243	0.0247	CbGeAlD
Hydrochlorothiazide—CA4—lymph node—thyroid cancer	0.00205	0.0209	CbGeAlD
Hydrochlorothiazide—CA2—lymph node—thyroid cancer	0.0017	0.0173	CbGeAlD
Hydrochlorothiazide—Photosensitivity—Doxorubicin—thyroid cancer	0.00161	0.00183	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Sorafenib—thyroid cancer	0.00161	0.00182	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Sorafenib—thyroid cancer	0.00161	0.00182	CcSEcCtD
Hydrochlorothiazide—Renal impairment—Epirubicin—thyroid cancer	0.00161	0.00182	CcSEcCtD
Hydrochlorothiazide—Purpura—Epirubicin—thyroid cancer	0.00159	0.0018	CcSEcCtD
Hydrochlorothiazide—Vascular purpura—Doxorubicin—thyroid cancer	0.00158	0.00179	CcSEcCtD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—thyroid cancer	0.00156	0.0804	CbGpPWpGaD
Hydrochlorothiazide—Hyponatraemia—Epirubicin—thyroid cancer	0.00154	0.00174	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00153	0.00173	CcSEcCtD
Hydrochlorothiazide—Pain in extremity—Epirubicin—thyroid cancer	0.00153	0.00173	CcSEcCtD
Hydrochlorothiazide—Hot flush—Doxorubicin—thyroid cancer	0.00151	0.00171	CcSEcCtD
Hydrochlorothiazide—Increased appetite—Doxorubicin—thyroid cancer	0.00151	0.00171	CcSEcCtD
Hydrochlorothiazide—Migraine—Epirubicin—thyroid cancer	0.00151	0.00171	CcSEcCtD
Hydrochlorothiazide—Affect lability—Epirubicin—thyroid cancer	0.00151	0.00171	CcSEcCtD
Hydrochlorothiazide—Menopausal symptoms—Doxorubicin—thyroid cancer	0.0015	0.0017	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.0015	0.0017	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Sorafenib—thyroid cancer	0.0015	0.0017	CcSEcCtD
Hydrochlorothiazide—Renal impairment—Doxorubicin—thyroid cancer	0.00149	0.00169	CcSEcCtD
Hydrochlorothiazide—Face oedema—Epirubicin—thyroid cancer	0.00148	0.00167	CcSEcCtD
Hydrochlorothiazide—Purpura—Doxorubicin—thyroid cancer	0.00147	0.00166	CcSEcCtD
Hydrochlorothiazide—Asthenia—Sorafenib—thyroid cancer	0.00146	0.00165	CcSEcCtD
Hydrochlorothiazide—Mood swings—Epirubicin—thyroid cancer	0.00145	0.00164	CcSEcCtD
Hydrochlorothiazide—Pruritus—Sorafenib—thyroid cancer	0.00144	0.00163	CcSEcCtD
Hydrochlorothiazide—Ataxia—Epirubicin—thyroid cancer	0.00144	0.00163	CcSEcCtD
Hydrochlorothiazide—Blood creatinine increased—Epirubicin—thyroid cancer	0.00143	0.00162	CcSEcCtD
Hydrochlorothiazide—Hyponatraemia—Doxorubicin—thyroid cancer	0.00142	0.00161	CcSEcCtD
Hydrochlorothiazide—Pain in extremity—Doxorubicin—thyroid cancer	0.00141	0.0016	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00141	0.0016	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Epirubicin—thyroid cancer	0.00141	0.0016	CcSEcCtD
Hydrochlorothiazide—Dry skin—Epirubicin—thyroid cancer	0.0014	0.00159	CcSEcCtD
Hydrochlorothiazide—Abdominal pain upper—Epirubicin—thyroid cancer	0.0014	0.00158	CcSEcCtD
Hydrochlorothiazide—Orthostatic hypotension—Epirubicin—thyroid cancer	0.0014	0.00158	CcSEcCtD
Hydrochlorothiazide—Migraine—Doxorubicin—thyroid cancer	0.00139	0.00158	CcSEcCtD
Hydrochlorothiazide—Affect lability—Doxorubicin—thyroid cancer	0.00139	0.00158	CcSEcCtD
Hydrochlorothiazide—Hypokalaemia—Epirubicin—thyroid cancer	0.00139	0.00158	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Sorafenib—thyroid cancer	0.00139	0.00158	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Epirubicin—thyroid cancer	0.00138	0.00157	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00138	0.00156	CcSEcCtD
Hydrochlorothiazide—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00138	0.00156	CcSEcCtD
Hydrochlorothiazide—Face oedema—Doxorubicin—thyroid cancer	0.00137	0.00155	CcSEcCtD
Hydrochlorothiazide—Gastritis—Epirubicin—thyroid cancer	0.00135	0.00153	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00135	0.00153	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Epirubicin—thyroid cancer	0.00135	0.00153	CcSEcCtD
Hydrochlorothiazide—Dizziness—Sorafenib—thyroid cancer	0.00134	0.00152	CcSEcCtD
Hydrochlorothiazide—Mood swings—Doxorubicin—thyroid cancer	0.00134	0.00152	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Epirubicin—thyroid cancer	0.00133	0.00151	CcSEcCtD
Hydrochlorothiazide—Ataxia—Doxorubicin—thyroid cancer	0.00133	0.00151	CcSEcCtD
Hydrochlorothiazide—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00133	0.0015	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Epirubicin—thyroid cancer	0.00132	0.0015	CcSEcCtD
Hydrochlorothiazide—Influenza—Epirubicin—thyroid cancer	0.00132	0.0015	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00131	0.00148	CcSEcCtD
Hydrochlorothiazide—Dry skin—Doxorubicin—thyroid cancer	0.0013	0.00147	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Epirubicin—thyroid cancer	0.0013	0.00147	CcSEcCtD
Hydrochlorothiazide—Vomiting—Sorafenib—thyroid cancer	0.00129	0.00147	CcSEcCtD
Hydrochlorothiazide—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00129	0.00146	CcSEcCtD
Hydrochlorothiazide—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00129	0.00146	CcSEcCtD
Hydrochlorothiazide—Hypokalaemia—Doxorubicin—thyroid cancer	0.00129	0.00146	CcSEcCtD
Hydrochlorothiazide—Angina pectoris—Epirubicin—thyroid cancer	0.00129	0.00146	CcSEcCtD
Hydrochlorothiazide—Rash—Sorafenib—thyroid cancer	0.00128	0.00145	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Sorafenib—thyroid cancer	0.00128	0.00145	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Doxorubicin—thyroid cancer	0.00128	0.00145	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00127	0.00144	CcSEcCtD
Hydrochlorothiazide—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00127	0.00144	CcSEcCtD
Hydrochlorothiazide—Headache—Sorafenib—thyroid cancer	0.00127	0.00144	CcSEcCtD
Hydrochlorothiazide—Gastritis—Doxorubicin—thyroid cancer	0.00125	0.00142	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Doxorubicin—thyroid cancer	0.00125	0.00141	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00125	0.00141	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Epirubicin—thyroid cancer	0.00124	0.0014	CcSEcCtD
Hydrochlorothiazide—Dysuria—Epirubicin—thyroid cancer	0.00124	0.0014	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Doxorubicin—thyroid cancer	0.00123	0.0014	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00123	0.00139	CcSEcCtD
Hydrochlorothiazide—Influenza—Doxorubicin—thyroid cancer	0.00122	0.00139	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Doxorubicin—thyroid cancer	0.00122	0.00139	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Epirubicin—thyroid cancer	0.00122	0.00138	CcSEcCtD
Hydrochlorothiazide—Nausea—Sorafenib—thyroid cancer	0.00121	0.00137	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00121	0.00137	CcSEcCtD
Hydrochlorothiazide—Weight increased—Epirubicin—thyroid cancer	0.0012	0.00136	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Doxorubicin—thyroid cancer	0.0012	0.00136	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Epirubicin—thyroid cancer	0.00119	0.00135	CcSEcCtD
Hydrochlorothiazide—Angina pectoris—Doxorubicin—thyroid cancer	0.00119	0.00135	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Epirubicin—thyroid cancer	0.00119	0.00134	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00117	0.00132	CcSEcCtD
Hydrochlorothiazide—Renal failure—Epirubicin—thyroid cancer	0.00116	0.00131	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—EPO—thyroid cancer	0.00116	0.0597	CbGpPWpGaD
Hydrochlorothiazide—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00116	0.00131	CcSEcCtD
Hydrochlorothiazide—Jaundice—Epirubicin—thyroid cancer	0.00115	0.0013	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Epirubicin—thyroid cancer	0.00115	0.0013	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Epirubicin—thyroid cancer	0.00115	0.0013	CcSEcCtD
Hydrochlorothiazide—Dysuria—Doxorubicin—thyroid cancer	0.00114	0.0013	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Doxorubicin—thyroid cancer	0.00114	0.0013	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00114	0.00129	CcSEcCtD
Hydrochlorothiazide—Sweating—Epirubicin—thyroid cancer	0.00113	0.00128	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Doxorubicin—thyroid cancer	0.00113	0.00128	CcSEcCtD
Hydrochlorothiazide—Haematuria—Epirubicin—thyroid cancer	0.00112	0.00127	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00112	0.00127	CcSEcCtD
Hydrochlorothiazide—Weight increased—Doxorubicin—thyroid cancer	0.00111	0.00126	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Epirubicin—thyroid cancer	0.00111	0.00126	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Epirubicin—thyroid cancer	0.00111	0.00125	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Doxorubicin—thyroid cancer	0.0011	0.00125	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Epirubicin—thyroid cancer	0.0011	0.00125	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Doxorubicin—thyroid cancer	0.0011	0.00124	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00108	0.00123	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Epirubicin—thyroid cancer	0.00108	0.00122	CcSEcCtD
Hydrochlorothiazide—Renal failure—Doxorubicin—thyroid cancer	0.00107	0.00121	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00107	0.00121	CcSEcCtD
Hydrochlorothiazide—Jaundice—Doxorubicin—thyroid cancer	0.00106	0.0012	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Epirubicin—thyroid cancer	0.00106	0.0012	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Doxorubicin—thyroid cancer	0.00106	0.0012	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Doxorubicin—thyroid cancer	0.00106	0.0012	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Epirubicin—thyroid cancer	0.00106	0.0012	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Epirubicin—thyroid cancer	0.00105	0.00119	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Epirubicin—thyroid cancer	0.00105	0.00119	CcSEcCtD
Hydrochlorothiazide—Sweating—Doxorubicin—thyroid cancer	0.00105	0.00118	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Epirubicin—thyroid cancer	0.00104	0.00118	CcSEcCtD
Hydrochlorothiazide—Haematuria—Doxorubicin—thyroid cancer	0.00104	0.00118	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Doxorubicin—thyroid cancer	0.00103	0.00117	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Doxorubicin—thyroid cancer	0.00102	0.00116	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Epirubicin—thyroid cancer	0.00102	0.00116	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Doxorubicin—thyroid cancer	0.00102	0.00115	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Epirubicin—thyroid cancer	0.001	0.00113	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Doxorubicin—thyroid cancer	0.000996	0.00113	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Epirubicin—thyroid cancer	0.000986	0.00112	CcSEcCtD
Hydrochlorothiazide—Flushing—Epirubicin—thyroid cancer	0.000982	0.00111	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Doxorubicin—thyroid cancer	0.000981	0.00111	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Doxorubicin—thyroid cancer	0.000979	0.00111	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000974	0.0011	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Doxorubicin—thyroid cancer	0.000972	0.0011	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Doxorubicin—thyroid cancer	0.000964	0.00109	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Epirubicin—thyroid cancer	0.000945	0.00107	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Doxorubicin—thyroid cancer	0.000943	0.00107	CcSEcCtD
Hydrochlorothiazide—Alopecia—Epirubicin—thyroid cancer	0.000935	0.00106	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Doxorubicin—thyroid cancer	0.000926	0.00105	CcSEcCtD
Hydrochlorothiazide—Erythema—Epirubicin—thyroid cancer	0.000921	0.00104	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Doxorubicin—thyroid cancer	0.000913	0.00103	CcSEcCtD
Hydrochlorothiazide—Flushing—Doxorubicin—thyroid cancer	0.000908	0.00103	CcSEcCtD
Hydrochlorothiazide—Flatulence—Epirubicin—thyroid cancer	0.000907	0.00103	CcSEcCtD
Hydrochlorothiazide—Tension—Epirubicin—thyroid cancer	0.000904	0.00102	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Epirubicin—thyroid cancer	0.000902	0.00102	CcSEcCtD
Hydrochlorothiazide—Nervousness—Epirubicin—thyroid cancer	0.000894	0.00101	CcSEcCtD
Hydrochlorothiazide—Back pain—Epirubicin—thyroid cancer	0.000891	0.00101	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Epirubicin—thyroid cancer	0.000885	0.001	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Doxorubicin—thyroid cancer	0.000874	0.000991	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Epirubicin—thyroid cancer	0.000868	0.000984	CcSEcCtD
Hydrochlorothiazide—Alopecia—Doxorubicin—thyroid cancer	0.000865	0.00098	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Epirubicin—thyroid cancer	0.000854	0.000969	CcSEcCtD
Hydrochlorothiazide—Erythema—Doxorubicin—thyroid cancer	0.000852	0.000966	CcSEcCtD
Hydrochlorothiazide—Anaemia—Epirubicin—thyroid cancer	0.000851	0.000965	CcSEcCtD
Hydrochlorothiazide—Agitation—Epirubicin—thyroid cancer	0.000846	0.000959	CcSEcCtD
Hydrochlorothiazide—Flatulence—Doxorubicin—thyroid cancer	0.00084	0.000952	CcSEcCtD
Hydrochlorothiazide—Tension—Doxorubicin—thyroid cancer	0.000836	0.000948	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Doxorubicin—thyroid cancer	0.000834	0.000946	CcSEcCtD
Hydrochlorothiazide—Malaise—Epirubicin—thyroid cancer	0.00083	0.000941	CcSEcCtD
Hydrochlorothiazide—Nervousness—Doxorubicin—thyroid cancer	0.000828	0.000938	CcSEcCtD
Hydrochlorothiazide—Vertigo—Epirubicin—thyroid cancer	0.000827	0.000938	CcSEcCtD
Hydrochlorothiazide—Syncope—Epirubicin—thyroid cancer	0.000826	0.000936	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Epirubicin—thyroid cancer	0.000824	0.000934	CcSEcCtD
Hydrochlorothiazide—Back pain—Doxorubicin—thyroid cancer	0.000824	0.000934	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Doxorubicin—thyroid cancer	0.000819	0.000929	CcSEcCtD
Hydrochlorothiazide—Palpitations—Epirubicin—thyroid cancer	0.000814	0.000922	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Epirubicin—thyroid cancer	0.000809	0.000917	CcSEcCtD
Hydrochlorothiazide—Cough—Epirubicin—thyroid cancer	0.000804	0.000911	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Doxorubicin—thyroid cancer	0.000803	0.00091	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000791	0.000896	CcSEcCtD
Hydrochlorothiazide—Anaemia—Doxorubicin—thyroid cancer	0.000788	0.000893	CcSEcCtD
Hydrochlorothiazide—Chest pain—Epirubicin—thyroid cancer	0.000784	0.000889	CcSEcCtD
Hydrochlorothiazide—Myalgia—Epirubicin—thyroid cancer	0.000784	0.000889	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Epirubicin—thyroid cancer	0.000784	0.000889	CcSEcCtD
Hydrochlorothiazide—Agitation—Doxorubicin—thyroid cancer	0.000783	0.000888	CcSEcCtD
Hydrochlorothiazide—Anxiety—Epirubicin—thyroid cancer	0.000781	0.000886	CcSEcCtD
Hydrochlorothiazide—Discomfort—Epirubicin—thyroid cancer	0.000775	0.000878	CcSEcCtD
Hydrochlorothiazide—Malaise—Doxorubicin—thyroid cancer	0.000768	0.000871	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Epirubicin—thyroid cancer	0.000767	0.000869	CcSEcCtD
Hydrochlorothiazide—Vertigo—Doxorubicin—thyroid cancer	0.000766	0.000868	CcSEcCtD
Hydrochlorothiazide—Syncope—Doxorubicin—thyroid cancer	0.000764	0.000866	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Doxorubicin—thyroid cancer	0.000763	0.000865	CcSEcCtD
Hydrochlorothiazide—Confusional state—Epirubicin—thyroid cancer	0.000758	0.000859	CcSEcCtD
Hydrochlorothiazide—Palpitations—Doxorubicin—thyroid cancer	0.000753	0.000854	CcSEcCtD
Hydrochlorothiazide—Oedema—Epirubicin—thyroid cancer	0.000752	0.000852	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Epirubicin—thyroid cancer	0.000752	0.000852	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Doxorubicin—thyroid cancer	0.000749	0.000849	CcSEcCtD
Hydrochlorothiazide—Cough—Doxorubicin—thyroid cancer	0.000744	0.000843	CcSEcCtD
Hydrochlorothiazide—Shock—Epirubicin—thyroid cancer	0.000739	0.000838	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Epirubicin—thyroid cancer	0.000736	0.000834	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Epirubicin—thyroid cancer	0.000734	0.000831	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000727	0.000824	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Doxorubicin—thyroid cancer	0.000725	0.000822	CcSEcCtD
Hydrochlorothiazide—Chest pain—Doxorubicin—thyroid cancer	0.000725	0.000822	CcSEcCtD
Hydrochlorothiazide—Myalgia—Doxorubicin—thyroid cancer	0.000725	0.000822	CcSEcCtD
Hydrochlorothiazide—Anxiety—Doxorubicin—thyroid cancer	0.000723	0.000819	CcSEcCtD
Hydrochlorothiazide—Discomfort—Doxorubicin—thyroid cancer	0.000717	0.000812	CcSEcCtD
Hydrochlorothiazide—Anorexia—Epirubicin—thyroid cancer	0.000716	0.000812	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Doxorubicin—thyroid cancer	0.000709	0.000804	CcSEcCtD
Hydrochlorothiazide—Hypotension—Epirubicin—thyroid cancer	0.000702	0.000796	CcSEcCtD
Hydrochlorothiazide—Confusional state—Doxorubicin—thyroid cancer	0.000701	0.000795	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000695	0.000788	CcSEcCtD
Hydrochlorothiazide—Oedema—Doxorubicin—thyroid cancer	0.000695	0.000788	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—HIF1A—thyroid cancer	0.000688	0.0355	CbGpPWpGaD
Hydrochlorothiazide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000685	0.000776	CcSEcCtD
Hydrochlorothiazide—Shock—Doxorubicin—thyroid cancer	0.000684	0.000776	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000681	0.000772	CcSEcCtD
Hydrochlorothiazide—Insomnia—Epirubicin—thyroid cancer	0.00068	0.000771	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Doxorubicin—thyroid cancer	0.000679	0.000769	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000677	0.035	CbGpPWpGaD
Hydrochlorothiazide—Paraesthesia—Epirubicin—thyroid cancer	0.000675	0.000765	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000672	0.000762	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Epirubicin—thyroid cancer	0.00067	0.00076	CcSEcCtD
Hydrochlorothiazide—Somnolence—Epirubicin—thyroid cancer	0.000668	0.000757	CcSEcCtD
Hydrochlorothiazide—Anorexia—Doxorubicin—thyroid cancer	0.000663	0.000751	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Epirubicin—thyroid cancer	0.000662	0.00075	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Epirubicin—thyroid cancer	0.000653	0.000741	CcSEcCtD
Hydrochlorothiazide—Hypotension—Doxorubicin—thyroid cancer	0.00065	0.000737	CcSEcCtD
Hydrochlorothiazide—Fatigue—Epirubicin—thyroid cancer	0.000648	0.000734	CcSEcCtD
Hydrochlorothiazide—Pain—Epirubicin—thyroid cancer	0.000643	0.000729	CcSEcCtD
Hydrochlorothiazide—Constipation—Epirubicin—thyroid cancer	0.000643	0.000729	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000634	0.000718	CcSEcCtD
Hydrochlorothiazide—Insomnia—Doxorubicin—thyroid cancer	0.000629	0.000713	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Doxorubicin—thyroid cancer	0.000624	0.000708	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Doxorubicin—thyroid cancer	0.00062	0.000703	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Epirubicin—thyroid cancer	0.000619	0.000702	CcSEcCtD
Hydrochlorothiazide—Somnolence—Doxorubicin—thyroid cancer	0.000618	0.000701	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000615	0.000697	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Doxorubicin—thyroid cancer	0.000612	0.000694	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Doxorubicin—thyroid cancer	0.000605	0.000685	CcSEcCtD
Hydrochlorothiazide—Fatigue—Doxorubicin—thyroid cancer	0.0006	0.00068	CcSEcCtD
Hydrochlorothiazide—Urticaria—Epirubicin—thyroid cancer	0.000597	0.000677	CcSEcCtD
Hydrochlorothiazide—Pain—Doxorubicin—thyroid cancer	0.000595	0.000674	CcSEcCtD
Hydrochlorothiazide—Constipation—Doxorubicin—thyroid cancer	0.000595	0.000674	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Epirubicin—thyroid cancer	0.000594	0.000673	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Epirubicin—thyroid cancer	0.000594	0.000673	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000587	0.0303	CbGpPWpGaD
Hydrochlorothiazide—Feeling abnormal—Doxorubicin—thyroid cancer	0.000573	0.00065	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000569	0.000645	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Epirubicin—thyroid cancer	0.000554	0.000628	CcSEcCtD
Hydrochlorothiazide—Urticaria—Doxorubicin—thyroid cancer	0.000552	0.000626	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Doxorubicin—thyroid cancer	0.00055	0.000623	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Doxorubicin—thyroid cancer	0.00055	0.000623	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.000544	0.0281	CbGpPWpGaD
Hydrochlorothiazide—Asthenia—Epirubicin—thyroid cancer	0.000539	0.000611	CcSEcCtD
Hydrochlorothiazide—Pruritus—Epirubicin—thyroid cancer	0.000532	0.000603	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000532	0.0274	CbGpPWpGaD
Hydrochlorothiazide—Diarrhoea—Epirubicin—thyroid cancer	0.000514	0.000583	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000512	0.000581	CcSEcCtD
Hydrochlorothiazide—Asthenia—Doxorubicin—thyroid cancer	0.000499	0.000566	CcSEcCtD
Hydrochlorothiazide—Dizziness—Epirubicin—thyroid cancer	0.000497	0.000563	CcSEcCtD
Hydrochlorothiazide—Pruritus—Doxorubicin—thyroid cancer	0.000492	0.000558	CcSEcCtD
Hydrochlorothiazide—Vomiting—Epirubicin—thyroid cancer	0.000478	0.000542	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Doxorubicin—thyroid cancer	0.000476	0.000539	CcSEcCtD
Hydrochlorothiazide—Rash—Epirubicin—thyroid cancer	0.000474	0.000537	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Epirubicin—thyroid cancer	0.000473	0.000537	CcSEcCtD
Hydrochlorothiazide—Headache—Epirubicin—thyroid cancer	0.000471	0.000534	CcSEcCtD
Hydrochlorothiazide—Dizziness—Doxorubicin—thyroid cancer	0.00046	0.000521	CcSEcCtD
Hydrochlorothiazide—Nausea—Epirubicin—thyroid cancer	0.000446	0.000506	CcSEcCtD
Hydrochlorothiazide—Vomiting—Doxorubicin—thyroid cancer	0.000442	0.000501	CcSEcCtD
Hydrochlorothiazide—Rash—Doxorubicin—thyroid cancer	0.000438	0.000497	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Doxorubicin—thyroid cancer	0.000438	0.000497	CcSEcCtD
Hydrochlorothiazide—Headache—Doxorubicin—thyroid cancer	0.000436	0.000494	CcSEcCtD
Hydrochlorothiazide—Nausea—Doxorubicin—thyroid cancer	0.000413	0.000468	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000331	0.0171	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000325	0.0168	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000325	0.0168	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000316	0.0163	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000299	0.0154	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—MINPP1—thyroid cancer	0.000244	0.0126	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000243	0.0125	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—MINPP1—thyroid cancer	0.000226	0.0117	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NDUFA13—thyroid cancer	0.000207	0.0107	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—PTGS2—thyroid cancer	0.000199	0.0102	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CHST14—thyroid cancer	0.000195	0.0101	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NDUFA13—thyroid cancer	0.000192	0.00991	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CHST14—thyroid cancer	0.00018	0.00932	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—MINPP1—thyroid cancer	0.00018	0.0093	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CCND1—thyroid cancer	0.000179	0.00926	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PRKAR1A—thyroid cancer	0.000178	0.00917	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—EPO—thyroid cancer	0.000175	0.00905	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—MINPP1—thyroid cancer	0.000173	0.00891	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—MINPP1—thyroid cancer	0.000165	0.00854	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000165	0.00851	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000165	0.00851	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000162	0.00838	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—HPGD—thyroid cancer	0.000157	0.00811	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—NRAS—thyroid cancer	0.000154	0.00797	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NDUFA13—thyroid cancer	0.000153	0.0079	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PPARG—thyroid cancer	0.00015	0.00775	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NDUFA13—thyroid cancer	0.000147	0.00758	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—MINPP1—thyroid cancer	0.000145	0.00751	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—HPGD—thyroid cancer	0.000145	0.00751	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CHST14—thyroid cancer	0.000144	0.00743	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NDUFA13—thyroid cancer	0.000141	0.00726	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CHST14—thyroid cancer	0.000138	0.00712	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000136	0.00701	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000136	0.00701	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—KRAS—thyroid cancer	0.000133	0.00686	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CHST14—thyroid cancer	0.000132	0.00683	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NDUFA13—thyroid cancer	0.000124	0.00639	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000123	0.00637	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IFNA2—thyroid cancer	0.000118	0.00608	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CHST14—thyroid cancer	0.000116	0.006	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—HPGD—thyroid cancer	0.000116	0.00599	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—HRAS—thyroid cancer	0.000113	0.00583	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—BRAF—thyroid cancer	0.000112	0.00581	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—HPGD—thyroid cancer	0.000111	0.00574	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—HPGD—thyroid cancer	0.000107	0.00551	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000106	0.00549	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—HIF1A—thyroid cancer	0.000104	0.00539	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000104	0.00535	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PTEN—thyroid cancer	0.000103	0.00532	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000102	0.00525	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—HPGD—thyroid cancer	9.37e-05	0.00484	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—TPR—thyroid cancer	9.02e-05	0.00466	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PRKAR1A—thyroid cancer	8.87e-05	0.00458	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—TPR—thyroid cancer	8.36e-05	0.00431	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PRKAR1A—thyroid cancer	8.22e-05	0.00424	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TP53—thyroid cancer	7.03e-05	0.00363	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	6.9e-05	0.00356	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	6.9e-05	0.00356	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.79e-05	0.0035	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—SLC5A5—thyroid cancer	6.75e-05	0.00349	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—TPR—thyroid cancer	6.66e-05	0.00344	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PRKAR1A—thyroid cancer	6.56e-05	0.00338	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—TPR—thyroid cancer	6.39e-05	0.0033	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PRKAR1A—thyroid cancer	6.29e-05	0.00324	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—SLC5A5—thyroid cancer	6.26e-05	0.00323	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—TPR—thyroid cancer	6.12e-05	0.00316	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PRKAR1A—thyroid cancer	6.03e-05	0.00311	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—RXRA—thyroid cancer	5.67e-05	0.00293	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—TPR—thyroid cancer	5.38e-05	0.00278	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PRKAR1A—thyroid cancer	5.3e-05	0.00273	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—RXRA—thyroid cancer	5.26e-05	0.00271	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—HRAS—thyroid cancer	5.17e-05	0.00267	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.16e-05	0.00267	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—SLC5A5—thyroid cancer	4.99e-05	0.00258	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—SLC5A5—thyroid cancer	4.78e-05	0.00247	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—SLC5A5—thyroid cancer	4.59e-05	0.00237	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—NRAS—thyroid cancer	4.39e-05	0.00227	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.34e-05	0.00224	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—RXRA—thyroid cancer	4.19e-05	0.00216	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—TP53—thyroid cancer	4.16e-05	0.00215	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—SLC5A5—thyroid cancer	4.03e-05	0.00208	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—RXRA—thyroid cancer	4.02e-05	0.00207	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—RXRA—thyroid cancer	3.85e-05	0.00199	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—KRAS—thyroid cancer	3.78e-05	0.00195	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PPARG—thyroid cancer	3.58e-05	0.00185	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—RXRA—thyroid cancer	3.39e-05	0.00175	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TP53—thyroid cancer	3.36e-05	0.00173	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PPARG—thyroid cancer	3.32e-05	0.00171	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—HRAS—thyroid cancer	3.21e-05	0.00166	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—AKT1—thyroid cancer	2.84e-05	0.00146	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTGS2—thyroid cancer	2.82e-05	0.00145	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PPARG—thyroid cancer	2.65e-05	0.00137	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTGS2—thyroid cancer	2.61e-05	0.00135	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PPARG—thyroid cancer	2.54e-05	0.00131	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTEN—thyroid cancer	2.46e-05	0.00127	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PPARG—thyroid cancer	2.43e-05	0.00126	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTEN—thyroid cancer	2.28e-05	0.00118	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PPARG—thyroid cancer	2.14e-05	0.0011	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTGS2—thyroid cancer	2.08e-05	0.00107	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTGS2—thyroid cancer	2e-05	0.00103	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTGS2—thyroid cancer	1.91e-05	0.000988	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTEN—thyroid cancer	1.82e-05	0.000937	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTEN—thyroid cancer	1.74e-05	0.000899	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTGS2—thyroid cancer	1.68e-05	0.000868	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTEN—thyroid cancer	1.67e-05	0.000861	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTEN—thyroid cancer	1.47e-05	0.000757	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—AKT1—thyroid cancer	1.42e-05	0.000731	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—AKT1—thyroid cancer	1.31e-05	0.000677	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—AKT1—thyroid cancer	1.05e-05	0.00054	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—AKT1—thyroid cancer	1e-05	0.000518	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—AKT1—thyroid cancer	9.62e-06	0.000496	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—AKT1—thyroid cancer	8.45e-06	0.000436	CbGpPWpGaD
